Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients with Genotype 1 Hepatitis C Virus Infection and Cirrhosis

BACKGROUND & AIMS: We aimed to evaluate the safety and effectiveness of 12 or 24 weeks treatment with ledipasvir and sofosbuvir, with or without ribavirin, in treatment-experienced patients with hepatitis C virus (HCV) genotype 1 infection and cirrhosis in routine clinical practice. Patients wer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Main Authors: Lim, Joseph K., Liapakis, Ann Marie, Shiffman, Mitchell L., Lok, Anna S., Zeuzem, Stefan, Terrault, Norah A., Park, James S., Landis, Charles S., Hassan, Mohamed, Gallant, Joel, Kuo, Alexander, Pockros, Paul J., Vainorius, Monika, Akushevich, Lucy, Michael, Larry, Fried, Michael W., Nelson, David R., Ben-Ari, Ziv
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034985/
https://ncbi.nlm.nih.gov/pubmed/29306043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.12.037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados